Akebia Therapeutics
AKBA
AKBA
79 hedge funds and large institutions have $46M invested in Akebia Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.17% less ownership
Funds ownership: 28.21% → 27.05% (-1.2%)
45% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 20
Holders
79
Holding in Top 10
1
Calls
$849K
Puts
$160K
Top Buyers
| 1 | +$1M | |
| 2 | +$908K | |
| 3 | +$399K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$370K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$311K |
Top Sellers
| 1 | -$4.3M | |
| 2 | -$1.83M | |
| 3 | -$247K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$103K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$89.7K |